The UK Government and the European Commission have today set out their proposed approaches to negotiations over the future relationship between the EU and the UK.
In a week that has seen a Global Talent visa launched, the ABPI has welcomed the Government’s ambition to build a future immigration system which supports the UK’s thriving life sciences sector.
The DHSC has announced a consultation into the Statutory Scheme. This looks at amending the payment percentages in the Branded Health Service Medicines (Costs) Regulations 2018.
Novartis has announced a collaboration with NHS England, the National Institute for Health Research and Oxford University.
The ABPI has welcomed the news that the Conservative Party have won a majority and looks forward to working with the new Government.
The Government has announced further details for how they will support pharmaceutical companies’ investments in the development of drugs that will treat AMR infections.
The NHS Confederation and the ABPI have today published a new report to help the NHS and life sciences industry work more closely together.
King’s College London, Wellcome and pharmaceutical company MSD announced a collaboration and licencing deal today that could lead to a new class of pain medications.
In response to concerns about the impact a US trade deal would have on medicine pricing, the ABPI continues to emphasise that in the UK, we have very strict rules which control medicine spend.
New figures published today by the ABPI show that the pharmaceutical industry continues to invest significantly in UK research and development, working with healthcare professionals and organisations to improve care for NHS patients.